KindlyMD, Inc. (NASDAQ:NAKA) Given Average Rating of "Hold" by Brokerages

Key Points

• Brokerage consensus: Five analysts give KindlyMD a consensus "Hold" (1 sell, 1 hold, 3 buy) with an average 12‑month price target of $0.75.
• Institutional interest: Several funds recently initiated or increased positions—Tower Research boosted its stake by 1,638% to 33,152 shares, Geode raised its holding by 76.2%, and CI Investments and others also added new stakes.
• Price and volatility: NAKA opened at $0.19 with a $131.8M market cap, a negative P/E and a beta of 17.12, and a one‑year range of $0.17–$34.77, signaling extreme past volatility.

KindlyMD, Inc. (NASDAQ:NAKA - Get Free Report) has been given a consensus recommendation of "Hold" by the five brokerages that are presently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and three have issued a buy rating on the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $0.75.

A number of research firms have issued reports on NAKA. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of KindlyMD in a research report on Friday, March 27th. Maxim Group reduced their price target on KindlyMD from $1.50 to $0.75 and set a "buy" rating on the stock in a research report on Monday, April 6th. TD Cowen began coverage on KindlyMD in a research report on Friday, April 10th. They issued a "buy" rating and a $1.00 price target on the stock. Finally, B. Riley Financial reduced their price target on KindlyMD from $1.00 to $0.50 and set a "buy" rating on the stock in a research report on Monday, February 23rd.

Institutional Investors Weigh In On KindlyMD

Hedge funds and other institutional investors have recently made changes to their positions in the business. Osaic Holdings Inc. acquired a new stake in shares of KindlyMD during the 2nd quarter worth about $215,000. Dynamic Technology Lab Private Ltd acquired a new stake in shares of KindlyMD during the 3rd quarter worth about $369,000. Geode Capital Management LLC raised its position in shares of KindlyMD by 76.2% during the 2nd quarter. Geode Capital Management LLC now owns 19,394 shares of the company's stock worth $484,000 after acquiring an additional 8,386 shares in the last quarter. Tower Research Capital LLC TRC raised its position in shares of KindlyMD by 1,638.4% during the 3rd quarter. Tower Research Capital LLC TRC now owns 33,152 shares of the company's stock worth $827,000 after acquiring an additional 31,245 shares in the last quarter. Finally, CI Investments Inc. acquired a new stake in shares of KindlyMD during the 3rd quarter worth about $995,000.

KindlyMD Price Performance

NAKA stock opened at $0.19 on Tuesday. The firm has a market capitalization of $131.79 million, a P/E ratio of -0.22 and a beta of 17.12. The business's 50-day moving average is $0.24 and its two-hundred day moving average is $0.41. KindlyMD has a 1 year low of $0.17 and a 1 year high of $34.77.

KindlyMD Company Profile

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.